Internal Medicine, Nephrology · Philadelphia, PA
NPI
1790190502
Since 2014
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
3400 Spruce St
Philadelphia, PA, 19104
Phone (215) 662-2637
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
874 services
Medicare patients, 2024
232
Average age 70
Drug cost, 2024
$162K
1,372 prescriptions
Company payments, 2023
$186
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sadichhya Lohani was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 127 times for 64 patients. In total Sadichhya Lohani billed 874 services in 20 codes, and Medicare paid $74K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 127 | 64 | $12.42 | $1,577 |
| 90935 Hemodialysis | Facility | 99 | 54 | $56.68 | $5,611 |
| 99214 Office E&M - Established | Facility | 80 | 52 | $62.25 | $4,980 |
| 99233 Hospital E&M - Subsequent | Facility | 74 | 39 | $95.14 | $7,040 |
| 99215 Office E&M - Established | Facility | 64 | 36 | $72.83 | $4,661 |
| 99232 Hospital E&M - Subsequent | Facility | 60 | 31 | $63.17 | $3,790 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 58 | 30 | $13.45 | $780 |
| 90999 Hemodialysis | Facility | 57 | 18 | $69.90 | $3,984 |
| 99223 Hospital E&M - Initial | Facility | 48 | 47 | $139.01 | $6,673 |
| 99215 Office E&M - Established | Office | 18 | 11 | $120.69 | $2,172 |
| 99214 Office E&M - Established | Office | 18 | 11 | $93.08 | $1,676 |
| 99222 Hospital E&M - Initial | Facility | 15 | 14 | $105.06 | $1,576 |
| 99205 Office E&M - New | Facility | 12 | 12 | $146.61 | $1,759 |
By year: 2022 $80K for 781 services; 2023 $71K for 674 services; 2024 $74K for 874 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sadichhya Lohani prescribed most often to Medicare patients was Amlodipine Besylate, with 105 prescriptions and refills. In total Sadichhya Lohani wrote 1,372 Medicare prescriptions that cost $162K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 105 | 240 | 31 | $650 |
| Losartan Potassium Generic | 99 | 256 | 34 | $1,166 |
| Carvedilol Generic | 98 | 227 | 29 | $906 |
| Clinisol Parenteral Amino Acid 15% No.5 | 64 | 64 | Under 11 | $16K |
| Chlorthalidone Generic | 61 | 146 | 23 | $1,012 |
| Bumetanide Generic | 53 | 83 | 14 | $2,407 |
| Calcium Acetate Generic | 53 | 70 | 13 | $2,516 |
| Atorvastatin Calcium Generic | 46 | 125 | 17 | $994 |
| Valsartan Generic | 45 | 115 | 14 | $1,483 |
| Olmesartan Medoxomil Generic | 38 | 96 | 11 | $1,095 |
| Hydrochlorothiazide Generic | 34 | 58 | Under 11 | $201 |
| Potassium Chloride Generic | 32 | 39 | Under 11 | $687 |
| Spironolactone Generic | 31 | 85 | 12 | $394 |
| Torsemide Generic | 28 | 64 | Under 11 | $353 |
| Hydralazine Hcl Generic | 26 | 31 | Under 11 | $197 |
Brand drugs: 154 claims; generic drugs: 1,218 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Sadichhya Lohani $186 ($186 in general payments such as food, travel and fees) from 2 companies. The largest payer was GlaxoSmithKline, LLC. with $119.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $119 |
| Vifor Pharma, Inc. | 1 | $66.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.